Osiris Therapeutics (OSIR) Declares $0.20 Special Dividend; 1% Yield
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
- Nasdaq, S&P 500 slip from record highs as yields and oil rebound
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Chip stock could soar nearly 200%, analyst says: "If you don’t buy it, they will"
- Musk rules out TSMC role in Terafab operations; Intel gains
Osiris Therapeutics (OSIR) Names New CFO and CBO
September 17, 2015 8:02 AM EDTOsiris Therapeutics (NASDAQ: OSIR) announced the appointment of Gregory Law, to serve as Chief Financial Officer and Dwayne Montgomery, to serve as Chief Business Officer.
Mr. Law has been employed with Osiris since 2014 as the Vice President of Finance and Principal Accounting Officer. Mr. Law has more than 25 years of finance and accounting experience in a variety of industries, including biotechnology, telecommunications, energy, private equity and consulting. Prior to joining Osiris in 2014, Mr. Law spent over a decade providing consulting services to public and private companies in the areas of interim CFO and controllership,... More



